跳至主要内容
临床试验/NCT05635292
NCT05635292已完成不适用

Addressing Disability Effectively With Psychosocial Telemedicine (ADEPT Study): An Open-label, Multicenter Pragmatic Randomized Control Trial

University of Pennsylvania2 个研究点 分布在 1 个国家目标入组 715 人开始时间: 2023年2月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
715
试验地点
2
主要终点
Change in the IBD Disability Index

研究概览

简要总结

This multi-site study will be implemented at 5 gastroenterology practices to recruit 420 adults with IBD to complete a baseline survey and enroll those with higher scores on a validated IBD-disability scale into a randomized controlled trial of telehealth-delivered cognitive behavioral therapy with a licensed psychologist versus usual care. The investigators aim to lay the foundations that will shift the paradigm of IBD clinical practice towards a new horizon of holistic and equitable high-value care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults ≥18 years old with a diagnosis of Crohn's disease (CD) or ulcerative colitis (UC)
  • Willingness to complete the baseline survey online. Participants in Aim 1 with moderate-to-severe disability based on the IBD Disability Index (IBD-DI) will be invited to the Aim 2 clinical trial
  • Able to consent and complete surveys in English.

排除标准

  • no/low disability (IBD-DI <35) on the baseline survey
  • inability or unwillingness to participate in telemedicine with a therapist
  • Have an existing relationship with a mental health specialist within the past 3 months
  • Lack of access to a computer, working internet connection, and a private environment to complete teletherapy sessions if they are randomized to this intervention

研究组 & 干预措施

Control

No Intervention

Tele-CBT

Experimental

干预措施: Tele-CBT (Behavioral)

结局指标

主要结局

Change in the IBD Disability Index

时间窗: 8 weeks

Change in the IBD Disability is estimated by the 14-item validated IBD Disability Index (IBD-DI) in the intervention group (telemedicine-delivered psychosocial care) vs control group (usual care) in patients with moderate-to-severe baseline IBD-related disability pre and post intervention (week 0 and week 8). Total score ranges from 0-100, interpreted as 0-20 (no disability), 20-35 (mild disability), 35-50 (moderate disability), and 50-100 (severe disability).

次要结局

  • Cost-benefits of telemedicine-delivered psychosocial care(8 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验